Showing results (11-20 of 46) with videos related to
Sort By:
Pageof 5
Expert Review of Anti-Infective Therapy|July 6, 2026
The changing picture of community acquired urinary tract infections in the US: a daunting prospectTeena Chopra, Glenn Tillotson, Angela DonaldMicroorganisms|November 27, 2025
Fecal Microbiota Transplantation in Animals: Therapeutics, Conservation, and FarmingKelly R Reveles, Joni Meehan, Glenn TillotsonAllergy and Asthma Proceedings|October 23, 2010
The burden of hospitalizations and emergency department visits with hereditary angioedema and angioedema in the United States, 2007Marya D Zilberberg, Thomas Jacobsen, Glenn TillotsonExpert Review of Anti-Infective Therapy|August 21, 2020
Global travel and Gram-negative bacterial resistance; implications on clinical managementNicolette Theriault, Glenn Tillotson, Christian E SandrockTherapeutic Advances in Gastroenterology|March 7, 2022
Transitions of care in Clostridioides difficile infection: a need of the hourSahil Khanna, James Lett, Cheri Lattimer, et al.Journal of Medical Economics|May 20, 2009
Assessing the economic merits of managing cytomegalovirus infection in organ and stem cell transplantationSuzanne Wait, Primrose Musingarimi, Andrew Briggs, et al.Open Forum Infectious Diseases|December 2, 2020
Antimicrobial Management of Respiratory Infections in Severe Acute Respiratory Syndrome Coronavirus 2 Patients: Clinical and Antimicrobial Stewardship Programs ConundrumsEllie J C Goldstein, Glenn Tillotson, Mark RedellOpen Forum Infectious Diseases|March 19, 2021
Heterogeneity of Recent Phase 3 Complicated Urinary Tract Infection Clinical TrialsSimon Portsmouth, Almasa Bass, Roger Echols, et al.Future Microbiology|May 17, 2018
Delafloxacin: an improved fluoroquinolone developed through advanced molecular engineeringMatteo Bassetti, Elda Righi, Davide Pecori, et al.Expert Review of Anti-Infective Therapy|December 5, 2008
Measuring the severity of Clostridium difficile infection: implications for management and drug developmentJaime Belmares, Dale N Gerding, Glenn Tillotson, et al.Pageof 5